WEX Introduces Specialized HRA to Help Employers Manage Rising Healthcare Costs for GLP-1 Weight-Loss Medications

PORTLAND, Maine--(BUSINESS WIRE)--WEX Inc. (NYSE: WEX), a global leader in intelligence-led payment and workflow solutions, today announced the launch of a Health Reimbursement Arrangement (HRA) designed to help employers manage the surging demand and escalating costs of GLP-1 medications. WEX's specialized solution enables organizations to carve out GLP-1 coverage into a defined-contribution HRA. This puts the power back to the employer amidst shifting economic conditions by helping protect th.